Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes (Q42813590)

7 November 2017

Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes (English)

1 reference

7 November 2017

1 reference

1 reference

1 reference

Tsutomu Wada

1

1 reference

7 November 2017

Masashi Hoshino

2

1 reference

7 November 2017

Yukari Kimura

3

1 reference

7 November 2017

Minoru Ojima

4

1 reference

7 November 2017

Tetsuro Nakano

5

1 reference

7 November 2017

Daisuke Koya

6

1 reference

7 November 2017

Hiroshi Tsuneki

7

1 reference

7 November 2017

Toshiyasu Sasaoka

8

1 reference

7 November 2017

8 March 2011

1 reference

American Journal of Physiology - Endocrinology and Metabolism

7 November 2017

1 reference

7 November 2017

300

1 reference

7 November 2017

6

1 reference

7 November 2017

E1112-23

1 reference

Insulin antagonizes interleukin-6 signaling and is anti-inflammatory in 3T3-L1 adipocytes

7 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

A new protein containing an SH2 domain that inhibits JAK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Alternate interferon signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Effect of interferon on glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Clinical Use of Interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

The JAK-STAT signaling pathway: input and output integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Structure and function of a new STAT-induced STAT inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Side effects of high-dose interferon therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Diabetes and suppressors of cytokine signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Antiviral actions of interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

A family of cytokine-inducible inhibitors of signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Chronic nicotine exposure enhances insulin-induced mitogenic signaling via up-regulation of alpha7 nicotinic receptors in isolated rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00370.2010

10.1152/AJPENDO.00370.2010

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference